Org.nr 983 644 600 2021 → 2022 Year-over-year analysis

CYTOVATION ASA: årsregnskap 2022 vs 2021

Weaker earnings

approved 2023-05-09; registry 2023-08-10; journal 2023 663166

Summary

What changed

Comparing Årsregnskap 2022 with 2021 for CYTOVATION ASA. Net result -34.37m NOK → -122.91m NOK. Equity 87.11m NOK → 51.08m NOK.

Pressures included: operating result weakened; net result weakened; equity eroded.

Also worth watching: paid-in equity reduced. All figures are taken from the published annual accounts for CYTOVATION ASA.

At a glance

Operating result

-33.71m NOK -122.06m NOK

-262.1%

Net result

-34.37m NOK -122.91m NOK

-257.7%

Equity

87.11m NOK 51.08m NOK

-41.4%

Cash

88.22m NOK 78.97m NOK

-10.5%

Total assets

107.45m NOK 83.92m NOK

-21.9%

↓
Operating result weakened

Operating result -33.71m NOK → -122.06m NOK. Calculated
↓
Net result weakened

Net result -34.37m NOK → -122.91m NOK. Calculated
↓
Equity eroded

Book equity 87.11m NOK → 51.08m NOK (equity ratio 81.1% → 60.9%). Calculated
↓
Cash fell

Bank deposits 88.22m NOK → 78.97m NOK (-10.5% YoY). Calculated

·
Paid-in equity reduced

Paid-in equity fell 99.11m NOK → 51.08m NOK — check capital reduction, conversion, or reclassification. Interpretation